APA (7th ed.) Citation

Reutter, T., Fassunke, J., Püsken, M., Weber, J., Binot, E., Eisert, A., . . . Michels, S. (2023). Durable response with sequential tyrosine kinase inhibitor treatment in a patient with ROS1 fusion-positive pancreatic adenocarcinoma: A case report. JCO precision oncology, 7, . https://doi.org/10.1200/PO.22.00467

Chicago Style (17th ed.) Citation

Reutter, Theresa, et al. "Durable Response with Sequential Tyrosine Kinase Inhibitor Treatment in a Patient with ROS1 Fusion-positive Pancreatic Adenocarcinoma: A Case Report." JCO Precision Oncology 7 (2023). https://doi.org/10.1200/PO.22.00467.

MLA (9th ed.) Citation

Reutter, Theresa, et al. "Durable Response with Sequential Tyrosine Kinase Inhibitor Treatment in a Patient with ROS1 Fusion-positive Pancreatic Adenocarcinoma: A Case Report." JCO Precision Oncology, vol. 7, 2023, https://doi.org/10.1200/PO.22.00467.